were paced at 320 beats/min except during ischemia. Left ventricular developed pressure (LVDP, end-systolic -enddiastolic pressure, mmHg) and ±dP/dt (mmHg/s) were continuously monitored. Coronary flow (ml/min) was continuously measured with an electromagnetic flow probe that was placed around the tube connected to the aorta.
Protocol for Measuring Cardiac Function
All hearts were perfused for a total of 120 min consisting of a 30-min pre-ischemia period followed by a 30-min global ischemia and 60 min reperfusion at 37°C. As shown in Fig 1, 4 groups were studied: control hearts (control group, n=12); hearts treated with SMS (1.67 ml/kg per day, ip) for 3 days (SMS group, n=15); SMS-treated hearts with 100 mol/L of 5-hydroxydecanoic acid sodium salt (5-HD) for 10 min of the pre-ischemia period (SMS + 5-HD group, n=7); hearts treated with 5-HD for 10 min of the preischemia period (5-HD group, n=7).
The dose of SMS used in the present study was the clinical maximal dose (20-100 ml, once a day) for the maximal effect of Radix Ginseng, which is a main element of SMS. 3, 4 
Measurement of Lactate and Lactate Dehydrogenase (LDH) in the Effluent
The lactate and LDH concentrations in the effluent at 15, 30 and 60 min after reperfusion were measured in the control, SMS, SMS + 5-HD, and 5-HD groups. Lactate was measured spectrophotometrically by monitoring hydrogen peroxide formation resulting from the enzymatic reaction with lactate oxidase. 5 LDH was assayed by an ultraviolet method using a LDH assay kit. Experimental protocol. All hearts were perfused for a total of 120 min, consisting of a 30-min pre-ischemia period followed by a 30-min global ischemia and 60-min reperfusion. The heart was perfused with Krebs-Henseleit solution with and without 5-HD during the pre-ischemia period. The SMS group was treated with SMS for 3 days before the induction of ischemia. 
Measurement of Hydroxyl Radicals
The amount of 2,5-DHBA (2,5-dihydroxybenzoic acid), an indicator of hydroxyl radicals, was measured using high-performance liquid chromatography coupled with electrochemical detection in the control group (n=8), SMS group (n=8), SMS + 5-HD group (n=7), and 5-HD group (n=7). This method is based on the chemical reaction of salicylic acid with hydroxyl radicals, yielding 2,3-DHBA, 2,5-DHBA and catechol as its derivatives in an approximate proportion of 49%, 40%, and 11%, respectively. 6 It is reported that salicylic acid with a concentration of 1 mmol/L traps approximately 10% of the theoretically possible hydroxyl radicals formed in vivo. 7 We used 2,5-DHBA rather than 2,3-DHBA because of its greater sensitivity for quantification of hydroxyl radicals production. The experimental procedure for the measurement of 2,5-DHBA was the same as just described except that the hearts were perfused with buffer containing 1 mmol/L salicylic acid. The pH of the buffer was readjusted after the addition of salicylic acid. Then the hearts were subjected to global ischemia for 30 min and reperfused for 30 min. The effluent was collected at the end of the perfusion and at 1, 2, 3, 5, 10, 15 and 30 min in the reperfusion period and stored at -80°C until assay.
Statistical Analysis
All values are presented as the mean ± SEM. The difference in hemodynamic variables over time between the control and treatment groups was assessed by two-way repeated measures analysis of variance (ANOVA). Student's t test assessed the differences in lactate, LDH and 2,5-DHBA concentrations between the 2 groups. Differences of p<0.05 were considered statistically significant.
Chemicals and Herbal Materials
Five-hydroxydecanoic acid sodium salt (5-HD) was purchased from Sigma Chemical Co (St Louis, MO, USA) and Shen-Mei-San was purchased from Pharmaceutical Factory of West China University of Medical Science (No. 980450, Chengdu, China).
Results

Effect of SMS on Post-Ischemic Recovery of LV Function
During the pre-ischemic period, all measured parameters, such as LVEDP, LVDP, ±dP/dt and coronary flow, were comparable between the groups. 
Effect of SMS on Lactate and LDH Concentrations in the Effluent
The lactate and LDH concentrations in the effluent were both significantly attenuated in the SMS-treated group compared with the control group at 15, 30 and 60 min of reperfusion, but were restored after pretreatment with 5-HD (Fig 6) . 5-HD alone did not affect the lactate and LDH concentrations.
Effect of SMS on 2,5-DHBA Concentrations in the Effluent
As shown in Fig 7, the 2,5-DHBA concentrations significantly increased during reperfusion in the control group. The 3-day treatment with SMS significantly decreased the baseline concentrations of 2,5-DHBA and significantly attenuated the rise of 2,5-DHBA concentrations during reperfusion. Pretreatment with 5-HD restored the baseline level of 2,5-DHBA and blocked the attenuation of the increase in 2,5-DHBA level induced by SMS.
As shown in Table 1 , the effects of SMS on postischemic left ventricular function of the heart perfused with the buffer containing 1 mmol/L of salicylic acid were similar with those without the salicylic acid.
Discussion
The results of the present study demonstrated that (1) 3 days treatment with SMS significantly inhibited the rise in LVEDP and improved the recovery of LVDP and ±dP/dt during reperfusion after 30 min of global ischemia, (2) the effect of SMS was blocked by pretreatment with a mitochondrial KATP channel blocker, 5-HD, and (3) lactate, LDH and 2,5-DHBA.
Effect of Shen-Mai-San on LV Function
The 3-day treatment with SMS significantly improved post-ischemic myocardial dysfunction, but it is not clear from the present study which element of SMS improved the cardiac function. SMS decreased both the LDH and lactate concentrations in the effluent during reperfusion, suggesting that lactate formation during ischemia was attenuated by SMS, which in turn suggests that SMS protected the heart against ischemic cellular damage.
Possible Mechanisms of Cardioprotection by SMS
Treatment with SMS significantly attenuated the rise in 2,5-DHBA concentrations in the effluent during reperfusion compared with the control group, suggesting that SMS inhibited the production of hydroxyl radicals in the heart during reperfusion. It has been reported that Panax ginsen, one of the elements of SMS, has an anti-oxidant effect via activation of the Cu, Zn-superoxide dismutase gene; 8 postischemic myocardial dysfunction is mediated in part through the generation of reactive oxygen species such as superoxide anion, hydrogen peroxide and hydroxyl radicals, 9 and of these, hydroxyl radical has the most important role. 10, 11 Therefore, it is highly likely that the improvement of cardiac function by SMS is the result of blockade of hydroxyl radical production during reperfusion. Furthermore, the attenuated concentration of 2,5-DHBA during reperfusion by SMS was restored by treatment with 5-HD, a mitochondrial KATP channel blocker, suggesting that the opening of mitochondrial KATP channels reduces the production of hydroxyl radicals during reperfusion. This is a somewhat different results from the study by Pain et al who reported that the opening of mitochondrial KATP channels produces free radicals and activates MAP kinase, thus protecting the heart against ischemia reperfusion injury. 12 On the other hand, it has been reported that a KATP channel opener, nicorandil, scavenges hydroxyl radicals and inhibits superoxide anion production in neutrophils in vitro. 13 Therefore, it is controversial whether the opening of KATP channel produces or scavenges hydroxyl radicals. One possible explanation is that the small amount of free radicals that mediates the ischemic preconditioning effect may be related to the opening of KATP channels, but the large amount of free radicals that is associated with ischemia -reperfusion injury may be scavenged by the opening of KATP channels, as shown in the present study.
Secondly, the cardioprotective effect by SMS may be mediated by opening the mitochondrial KATP channels of cardiac myocytes, because the improvement in myocardial dysfunction by SMS after global ischemia was completely abolished by pretreatment with a mitochondrial KATP channel inhibitor, 5-HD. Recently, it was reported that activation of protein kinase C opens the mitochondrial KATP channels, 14 and that opening is currently believed to be critically important in protecting the myocardium against ischemic injury. 15 Furthermore, nicorandil, which opens both sarcolemmal and mitochondrial KATP channels, has been reported to protect the heart against ischemic injury. 16, 17 Thirdly, in the present study, treatment with SMS increased the coronary flow at baseline before global ischemia and at 15, 30 and 60 min of reperfusion as compared with the control saline-treated group. This suggests that SMS by itself has a vasodilating action and blocks coronary artery vasoconstriction and thrombus formation in intramyocardial small vessels, thus inhibiting the so-called 'no-reflow' phenomenon during reperfusion. The improvement in myocardial dysfunction after global ischemia may also be related to this coronary flow-increasing effect of SMS. The increase in coronary flow by SMS before ischemia and during reperfusion was completely blocked by the pretreatment with 5-HD, suggesting that the increase in coronary flow by SMS was caused by opening the mitochondrial KATP channel. However, as it is widely accepted that all types of KATP channel blockers affect not only the mitochondrial KATP channels but also the sarcolemmal KATP channels to some extent, it is likely that the dilatation of the coronary artery by SMS was caused by the opening of the sarcolemmal KATP channels. In addition, it is well known that coronary artery dilatation is mediated through the production of nitric oxide, 18 and hydroxyl radicals are reported to impair nitric oxide-mediated coronary vasodilatation in rats by reducing nitric oxide release. 19 Therefore, the increase in coronary flow by SMS might also be caused by a reduction of hydroxyl radical production during reperfusion.
Clinical Implications
SMS clearly protected the myocardium against postischemic myocardial dysfunction in rats when given daily for 3 days before ischemia. Basically, SMS is chronically administered to patients with coronary artery disease in China and if given to patients with angina pectosis, will protect against post-ischemic myocardial dysfunction. Furthermore, it can be expected that SMS would improve the myocardial dysfunction during reperfusion after percutaneous transluminal coronary angioplasty for myocardial infarction. Consequently, SMS may be beneficial for patients with coronary artery disease and further clinical trials are warranted.
